The development of CTNZ was made possible by a three-year seeding grant from the Auckland Cancer Society and the support of the Faculty of Medical and Health Sciences, The University of Auckland.

Auckland Cancer Society

We would also like to acknowledge the significant contributions made by both Roche Products (New Zealand) Ltd and Novartis New Zealand Ltd in the form of unrestricted grants supporting infrastructure development, and by NZ Oil Services Ltd, Wellington, the Cancer Society of New Zealand: Canterbury & West Coast Division, and the Van de Veer Institute, Christchurch for providing office space and support for CTNZ staff working off-site.

Roche Products (New Zealand) Ltd

Novartis New Zealand Ltd

Cancer Society of New Zealand: Canterbury & West Coast Division

Van de Veer Institute, Christchurch